RG

Ramilaben Ghemarbhai Chaudhari

Active Director Director DIN 08171094
DIN 08171094 First appointment Jul 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Jul 2018
Shareholding value •••• Premium profile

About Ramilaben Ghemarbhai Chaudhari

Data last updated:

Ramilaben Ghemarbhai Chaudhari is a Director at Harsiddhi Overseas Private Limited (since 2021), Designated Partner at Banas Cancer And Research Institute Llp (since 2026) and Director at Akshar Pathology Laboratory Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Trading and Healthcare. The largest current company by reported revenue is Harsiddhi Overseas Private Limited at ₹9.02 Cr (FY 2024).

DIN 08171094
Primary Designation Director
Industry Trading
First Appointment 02 Jul 2018
Oldest Company Age 8 yrs
Largest company Harsiddhi Overseas Private Limited · ₹9.02 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Harsiddhi Overseas Private Limited U51909GJ2021PTC124347
Director23 Jul 20212021₹9.02 Cr (FY 2024)Active
Designated Partner09 Feb 20262026Active
Director05 Sep 20232023Active
Designated Partner08 Jun 20222022Active
Rensat Pharma Private Limited U51909GJ2018PTC101735
Director02 Jul 20182018Active

Directorship timeline

Open interactive timeline →
Rensat Pharma Private Limited
Harsiddhi Overseas Private Limited
Adarsh Path Labs Llp
Akshar Pathology Laboratory Private Limited
Premium access

Shareholding and investment profile for Ramilaben Ghemarbhai Chaudhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramilaben Ghemarbhai Chaudhari

Ramilaben Ghemarbhai Chaudhari currently holds 5 directorships: Harsiddhi Overseas Private Limited (Director, since 23 Jul 2021, revenue ₹9.02 Cr (FY 2024)); Banas Cancer And Research Institute Llp (Designated Partner, since 09 Feb 2026); Akshar Pathology Laboratory Private Limited (Director, since 05 Sep 2023); Adarsh Path Labs Llp (Designated Partner, since 08 Jun 2022); Rensat Pharma Private Limited (Director, since 02 Jul 2018).

Ramilaben Ghemarbhai Chaudhari was first appointed on 02 Jul 2018 as Director at Rensat Pharma Private Limited. The most recent appointment on record is 09 Feb 2026 at Banas Cancer And Research Institute Llp.

The current boards of Ramilaben Ghemarbhai Chaudhari's companies include Ghemarbhai Kanjibhai Chaudhari (Harsiddhi Overseas Private Limited), Mohitkumar Himmatlal Nakrani (Harsiddhi Overseas Private Limited), Geeta Itesh Khatwani (Banas Cancer And Research Institute Llp), Maniben Ghemarbhai Chaudhary (Banas Cancer And Research Institute Llp), Mukeshkumar Prahladji Chaudhary (Banas Cancer And Research Institute Llp), Rati Rushabh Kothari (Banas Cancer And Research Institute Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available